Detected ·
MoleSense
CHF 90K—
Swiss healthtech startup MoleSense, an EPFL spin-off, secured up to CHF 90,000 in non-dilutive funding from Biopôle's Investment Programme. The company developed a molecular wearable patch that continuously monitors proteins and hormones in sweat for high-risk pregnancy care, eliminating the need for blood draws.
- Website
- www.molesense.ch
- linkedin.com/company/molesense
- Amount
- CHF 90 000 CHF
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-03 08:10:29 UTC
- Signal ID
- 3ec0d13a-6f66-40d8-85b4-a517781521b1
As the API returns it
{
"id": "3ec0d13a-6f66-40d8-85b4-a517781521b1",
"created_at": "2026-07-03T08:10:29.774243Z",
"company_name": "MoleSense",
"company_website_url": "www.molesense.ch",
"company_linkedin_url": "https://www.linkedin.com/company/molesense",
"event_type": "funding",
"funding_amount": 90000,
"funding_currency": "CHF",
"funding_stage": null,
"message": "*Swiss healthtech startup MoleSense, an EPFL spin-off, secured up to CHF 90,000 in non-dilutive funding from Biopôle's Investment Programme. The company developed a molecular wearable patch that continuously monitors proteins and hormones in sweat for high-risk pregnancy care, eliminating the need for blood draws.*"
}